DSP Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.24 %Nav, as on 25-02-2025

  • Previous Nav

  • Net Change on 25-02-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
DSP Healthcare Fund - Regular Plan - Growth -5.53 -9.60 12.32 20.93 25.06 23.51
BSE Health Care - TRI -6.61 -9.15 10.67 19.98 23.65 15.26
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 12.32 20.93 25.06 1.91 3,197.52
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 6.33 18.76 23.68 1.82 8,160.74
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 13.66 22.88 26.21 1.93 4,917.81
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 12.23 22.81 24.70 1.94 3,521.93
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 9.20 17.16 23.60 1.94 2,652.24
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 6.77 18.80 22.38 2.16 1,211.73

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Suven Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Globus Medical Inc

  • Illumina Inc

  • Gland Pharma Limited

  • Apollo Hospitals Enterprise Limited

  • Laurus Labs Limited

  • Alembic Pharmaceuticals Limited

  • Concord Biotech Limited

  • Vijaya Diagnostic Centre Limited

  • Sai Life Sciences Limited

  • Intuitive Surgical Inc

  • Kovai Medical Center and Hospital Limited

  • Pfizer Limited

  • Procter & Gamble Health Limited

  • Indoco Remedies Limited

  • Unichem Laboratories Limited

  • ICICI Lombard General Insurance Company Limited

  • Narayana Hrudayalaya Ltd.

  • Emcure Pharmaceuticals Limited

  • Abbott Laboratories

  • Aarti Drugs Limited

  • TREPS / Reverse Repo Investments

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Alkem Laboratories Limited

  • Thyrocare Technologies Limited

  • Lupin Limited

  • Jupiter Life Line Hospitals Limited

  • Medplus Health Services Limited

  • Laxmi Dental Limited

  • Grail Inc

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹3,197.52 crore. DSP Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.09(0.24%)yesterday to ₹37.366.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The DSP Healthcare Fund is managed by Chirag Dagli .

Fund House Contact

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021

+91 (22) 66578000
service@dspim.com
+91 (22) 66578181